Master Services Agreement for Drug Product Development and Manufacturing (the “Agreement”)Master Services Agreement • February 27th, 2024 • Vaxcyte, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 27th, 2024 Company IndustryWHEREAS, Customer is engaged in the development and research of certain products and requires assistance in the development and manufacture of product;
Master Services Agreement for Drug Product Development and Manufacturing (the “Agreement”)Master Services Agreement • February 27th, 2023 • Vaxcyte, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 27th, 2023 Company IndustryWHEREAS, Customer is engaged in the development and research of certain products and requires assistance in the development and manufacture of product;
Master Services Agreement for Drug Product Development and Manufacturing (the “Agreement”)Master Services Agreement • August 8th, 2022 • Vaxcyte, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 8th, 2022 Company IndustryWHEREAS, Customer is engaged in the development and research of certain products and requires assistance in the development and manufacture of product;